Cervical cancer worldwide

GLOBOCAN 2012 v1.0. Cervical Cancer Estimated Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed March 26, 2018. World Health Organization. Human papillomavirus (HPV) and cervical cancer. http://www.who.int/mediacentre/factsheets/fs380/en/. Accessed March 26, 2018. Bosch FX, Broker TR, Forman D et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine 2013 31;31 suppl 7:H1-31. Lim, 2017, Barriers to utilisation of cervical cancer screening in Sub Saharan Africa: a systematic review, Eur J Cancer Care, 26, 1, 10.1111/ecc.12444 Ekwunife, 2017, Challenges in cost-effectiveness analysis modelling of HPV vaccines in low- and middle-income countries: a systematic review and practice recommendations, Pharmacoeconomics, 35, 65, 10.1007/s40273-016-0451-7 Walboomers, 1999, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol, 189, 12, 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F Yim, EK, Park JS. The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer Res Treat 37(6):319–24. Food and Drug Administration. Human Papillomavirus Vaccine. https://www.fda.gov/biologicsbloodvaccines/vaccines/approvedproducts/ucm172678.htm. Accessed April 1, 2018. Markowitz, 2012, Human papillomavirus vaccine introduction–the first five years, Vaccine, 30, F139, 10.1016/j.vaccine.2012.05.039 Van Kriekinge G, 2014, Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths, Vaccine, 32, 733, 10.1016/j.vaccine.2013.11.049 Brotherton, 2011, Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study, Lancet, 377, 2085, 10.1016/S0140-6736(11)60551-5 Global Alliance for Vaccine Initiatives. Human papillomavirus vaccine support. https://www.gavi.org/support/nvs/human-papillomavirus/. Accessed April 1, 2018. Hanson, 2015, Gavi HPV programs: application to implementation, Vaccine, 3, 408, 10.3390/vaccines3020408 Cunningham, 2014, HPV vaccine acceptability in Africa: a systematic review, Prev Med, 69, 274, 10.1016/j.ypmed.2014.08.035 Chakkalakal, 2013, Implementing clinical guidelines in low-income settings: a review of literature, Glob Public Health, 8, 784, 10.1080/17441692.2013.815794 World Health Organization. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention 2013. Mvundura, 2014, Estimating the costs of cervical cancer screening in high-burden Sub-Saharan African countries, Int J Gynecol Obstet, 126, 151, 10.1016/j.ijgo.2014.02.012 Goldie, 2006, Cost-effectiveness of cervical cancer screening, Vaccine, 24, 164, 10.1016/j.vaccine.2006.05.114 Sankaranarayanan, 1998, Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors, Cancer, 83, 2150, 10.1002/(SICI)1097-0142(19981115)83:10<2150::AID-CNCR13>3.0.CO;2-0 1999, Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting, Lancet, 353, 869, 10.1016/S0140-6736(98)07033-0 Arbyn, 2008, Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India, Int J Cancer, 123, 153, 10.1002/ijc.23489 Sankaranarayanan, 2004, Accuracy of visual screening for cervical neoplasia: Results from an IARC multicenter study in India and Africa, Int J Cancer, 110, 907, 10.1002/ijc.20190 Sangwa-Lugoma, 2006, Visual inspection as a cervical cancer screening method in primary healthcare setting in Africa, Int J Cancer, 119, 1389, 10.1002/ijc.21972 Catarino, 2018, Accuracy of combinations of visual inspection using acetic acid or lugol iodine to detect cervical precancer: a meta-analysis, Int J Gynecol Obstet, 125, 545 Madzima, 2017, Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women, Can Fam Physician, 63, 597 Mezei, 2017, Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review, Int J Cancer, 141, 437, 10.1002/ijc.30695 Senapathy, 2011, The present scenario of cervical cancer control and HPV epidemiology in India: an outline, Asian Pac J Cancer Prev, 12, 1107 Maza, 2017, Cervical precancer treatment in low- and middle-income countries: a technology overview, J Glob Oncol, 3, 400, 10.1200/JGO.2016.003731 Gage, 2003, Follow-up care of women with an abnormal cytology in a low-resource setting, Cancer Detect Prev, 27, 466, 10.1016/j.cdp.2003.09.004 2009, Global guidance for cervical cancer prevention and control, FIGO, 1 Small, 2017, Cervical cancer: a global health crisis, Cancer, 123, 2404, 10.1002/cncr.30667 Chuang, 2016, Management and care of women with invasive cervical cancer: American Society of Clinical Oncology resource-stratified clinical practice guideline, J Glob Oncol, 2, 311, 10.1200/JGO.2016.003954 Dastidar, 2016, Is neo-adjuvant chemotherapy a better option for management of cervical cancer patients of rural India?, Indian J Cancer, 53, 56, 10.4103/0019-509X.180826 Schmeler, 2013, The Central America Gynecologic Oncology Education Program (CONEP): improving gynecologic oncology education and training on a global scale, Gynecol Oncol, 129, 445, 10.1016/j.ygyno.2013.03.013 Chuang, 2014, Teaching gynecologic oncology in low resource settings: a collaboration of healthvolunteers overseas and the society of gynecologic oncology, Gynecol Oncol, 135, 580, 10.1016/j.ygyno.2014.10.002 Chuang, 2016, Sister Society meeting on global education development and collaboration: meeting report, Int J Gynecol Cancer, 26, 1186, 10.1097/IGC.0000000000000735 LaVigne, 2017, Cervical cancer in low and middle income countries: addressing barriers to radiotherapy delivery, Gynecol Oncol Rep, 22, 16, 10.1016/j.gore.2017.08.004 Suneja, 2017, American Brachytherapy Society: brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries, Brachytherapy, 16, 85, 10.1016/j.brachy.2016.10.007 World Health Organization. Palliative Care. http://www.who.int/news-room/fact-sheets/detail/palliativecare. Accessed May 8, 2018. Rhee, 2018, Factors affecting palliative care development in Africa: In-country experts’ perception in seven countries, J Pain Symptom Manage, 55, 1313, 10.1016/j.jpainsymman.2018.01.009 Luyirika, 2016, Best practices in developing a national palliative care policy in resource limited settings: lessons from five African countries, Ecancermedicalscience, 10, 652, 10.3332/ecancer.2016.652 Lima, 2015, Palliative care and pain treatment in the global health agenda, Pain, 156, S115, 10.1097/01.j.pain.0000460349.23083.0b Osman, 2018, Palliative care in the global setting: ASCO resource-stratified practice guideline, J Glob Oncol, 4, 1 Kelly, 2017, A systematic review and meta-analysis of studies evaluating the performance of point-of-care tests for human papillomavirus screening, Sex Transm Infect, 93, S36, 10.1136/sextrans-2016-053070